# Stevanato Group S.p.A. (STVN)

> Source: Nexqual · https://nexqual.com/STVN · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Stevanato Group S.p.A. (STVN), nexqual.com/STVN" · informational, not investment advice.

**Price:** USD 19.5 (+3.61% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 18.82 · day 18.83–19.88 · 52w 12.89–27.99 · market cap $5.33B · NYQ

## Key facts
- 1 of 80 tracked superinvestors hold STVN (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Total return with dividends: 1Y -29.1% vs S&P 500 +14.9%; 5Y -20.4% vs S&P 500 +80.3%.
- Next earnings: 2026-11-03, EPS estimate USD 0.18, revenue estimate $321M.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold STVN. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.02% | $11.0M | Added +288.1% |

## Analysts
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-09 | UBS | Target lowered | Neutral | $28 → $23 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | -29.1% | -20.4% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -29.2% | -4.5% |
| Volatility (annualized) | 45.4% | 47.0% |
| Max drawdown | -51.4% (Oct 2025→Mar 2026) | -59.4% (Aug 2023→Mar 2026) |

## Peers (Medical Instruments & Supplies)
MMED (MiniMed Group, Inc.) USD 18.29 +2.75% · MMSI (Merit Medical Systems, Inc.) USD 93.94 +2.78% · TFX (Teleflex Incorporated) USD 136.58 +4.74% · BLCO (Bausch + Lomb Corporation) USD 17.43 +1.46% · ICUI (ICU Medical, Inc.) USD 168.33 +4.66% · NVST (Envista Holdings Corporation) USD 23.97 +3.36%

## More
Full page: https://nexqual.com/STVN · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.18 | $0.18 | -2.8% | $320.7M | 10 |
| Next quarter (ends 2026-12-31) | $0.24 | $0.24 | -1.7% | $371.2M | 9 |
| Current fiscal year (ends 2026-12-31) | $0.70 | $0.70 | -0.6% | $1.27B | 13 |
| Next fiscal year (ends 2027-12-31) | $0.83 | $0.83 | -0.4% | $1.38B | 13 |